HbA1c screening for the diagnosis of diabetes. Reply to Brož J, Brabec M, Krollová P et al [letter]-Reference-Cited by-同舟云学术

HbA1c screening for the diagnosis of diabetes. Reply to Brož J, Brabec M, Krollová P et al [letter]

Published:2023-06-05 Issue:8 Volume:66 Page:1578-1579
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Young Katherine G.^ORCID,McGovern Andrew P.^ORCID,Barroso Inês^ORCID,Hattersley Andrew T.^ORCID,Jones Angus G.^ORCID,Shields Beverley M.^ORCID,Thomas Nicholas J.^ORCID,Dennis John M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00125-023-05939-y.pdf

Reference6 articles.

1. Brož J, Brabec M, Krollová P, Fačkovcová L, Michalec J (2023) HbA1c screening for the diagnosis of diabetes. Diabetologia. https://doi.org/10.1007/s00125-023-05924-5

2. Young KG, McGovern AP, Barroso I et al (2022) The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis. Diabetologia 66(2):300–309. https://doi.org/10.1007/s00125-022-05824-0

3. Brož J, Malinovská J, Nunes M et al (2020) Prevalence of diabetes and prediabetes and its risk factors in adults aged 25–64 in the Czech Republic: a cross-sectional study. Diabetes Res Clin Pract 170:108470. https://doi.org/10.1016/j.diabres.2020.108470

4. National Institute for Health and Care Excellence (2017) Type 2 diabetes: prevention in people at high risk. 1.19 Metformin. Available from www.nice.org.uk/guidance/PH38/chapter/Recommendations#metformin. Accessed 11 April 2023

5. Young KG, McDonald TJ, Shields BM (2022) Glycated haemoglobin measurements from UK Biobank are different to those in linked primary care records: implications for combining biochemistry data from research studies and routine clinical care. Int J Epidemiol 51(3):1022–1024. https://doi.org/10.1093/ije/dyab265